Non-prescribing of clozapine for outpatients with schizophrenia in real-world settings: The clinicians’ perspectives
Abstract Clozapine is the gold standard for treating treatment-resistant schizophrenia although continuously underutilized. Previous surveys of clinicians have found that some of the most frequently cited barriers to clozapine prescribing are related to the blood-monitoring requirements. However, th...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2023-12-01
|
| Series: | Schizophrenia |
| Online Access: | https://doi.org/10.1038/s41537-023-00423-3 |